AzTrials
AzTrials

ConstipationNCT06788392

Nursing Homes on Constipation and General Comfort

A study testing reminiscence therapy in people with Constipation and Nursing Caries, run by Giresun Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Effect of Reminiscence Therapy on Constipation Applied to Elderly Individuals Staying in a Nursing Home in Giresun Province Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Constipation, Nursing Caries
What is being tested?
reminiscence therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2024to 1 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Those aged 65 and over,
  • Able to answer all questions and be communicative,
  • Scoring 24 or above from the Mini Mental test,
  • Agreeing to participate in the research,
  • Diagnosed with constipation by the institution physician and meeting the Rome III Constipation Diagnostic Criteria,
  • There is no deterioration in skin integrity or infection in the abdominal area,
  • No diarrhea,
  • Individuals without a history of abdominal surgery will be included in the study.

Who cannot join

  • Psychiatric drug users,
  • Those who score below 24 on the Mini Mental Test,
  • Those who do not meet the Rome III Diagnostic Criteria for Constipation,
  • Those with impaired skin integrity or infection in the abdominal area,
  • People with diarrhoea,
  • History of abdominal surgery Those who refused to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Giresun Huzurevi Yaşli Bakim Ve Rehabilitasyon Merkezi

    Giresun, Merkez, 28000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Reminiscence Therapy Applied to Elderly Individuals Staying in Nursing Homes on Constipation and General Comfort

The Effect of Reminiscence Therapy on Constipation Applied to Elderly Individuals Staying in a Nursing Home in Giresun Province

Read the detailed description

Research; This study will be conducted to determine the effect of reminiscence therapy, given once or twice a week to elderly people living in nursing homes, on constipation by reducing stress levels. It is thought that the results obtained will provide evidence for reducing constipation, which significantly limits life. Patients who complain of constipation at the Nursing Home Elderly Care and Rehabilitation Center, who voluntarily agree to participate in the research and who meet the sample selection criteria will be included in the study. Patient information will be collected and the research pre-test, post-test and application will be carried out face to face.

Being tested
reminiscence therapy
Keywords
the elderly, constipation, comfort, reminiscence therapy
Medical subject headings
Constipation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • reminiscence therapyOther

    Reminiscence Therapy is a supportive care model that has been used in recent years and increases life comfort.

Study groups in NCT06788392
Study groupRoleWhat they receive
interventionalExperimentalGroup receiving reminiscence therapy 2 days a week
Receives: Other: reminiscence therapy
controlNo interventionThe group in which no intervention and receiving routine nursing care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Constipation Severity Scale (CSS) General Comfort

    It was developed by Varma et al. in 2008. It is a scale for determining the frequency, intensity and difficulty/difficulty during defecation.

    Measured: Constipation levels will be measured at the begining of the study (pre-test) and end of the intervention of the 5 weeks (post test)

  2. Defecation Monitoring Form in a Standard Diary (DMFSD)

    In the form developed by Pamuk et al. (2003) there is a 7-day follow-up schedule consisting of 5 items, including the number of defecation, the amount of stool, the stool consistency, the feeling of buckling during defecation and the feeling of not fully emptying after defecation. For each symptom of constipation, all scores collected during the pre-treatment (7 days), sequence of application (21 days) and post-treatment (7 days) days were calculated by dividing the number of defecations performed within the same days.

    Measured: Constipation status will be monitored at the beginning of the study and daily for 5 weeks

  3. General Comfort Questionnaire

    It was developed by Kolcaba in 1992. A validity and reliability study was conducted by Kuğuoğlu and Karabacak in 2004. The General Comfort Scale is used to determine the comfort needs and to evaluate the state of achieving the result of increasing the expected comfort with the nursing interventions that constitute comfort, which includes three levels (relief, relaxation and superiority) and four dimensions (physical, psychospiritual, sociocultural and environmental) that constitute the theoretical factors of comfort.

    Measured: Comfort levels will be measured at the begining of the study (pre-test) and end of the intervention of the 5 weeks (post test)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2025
  2. Study start1 Sep 2024
  3. Primary completion12 Jan 2025
  4. Study completion1 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Block randomisation will be used to ensure that the number of patients in each group is balanced. Patients will be divided into two groups, each group consisting of at least 38 people, by a statistician who is not involved in the study, using a table of random numbers.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06788392
Sponsor's protocol ID
AIBU-SBF-KK-01
Other IDs
Kevser KASAP
Status last verified
Feb 2025
First submitted
2 Dec 2024
Last updated
19 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It is the request of the individuals who participated in my study.

Questions about this trial

What is this clinical trial studying?

A study testing reminiscence therapy in people with Constipation and Nursing Caries, run by Giresun Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Constipation Severity Scale (CSS) General Comfort (time frame: Constipation levels will be measured at the begining of the study (pre-test) and end of the intervention of the 5 weeks (post test)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in